Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Crawford Nomination For FDA Commissioner Put On Hold By Senate Democrats

This article was originally published in The Pink Sheet Daily

Executive Summary

Sens. Clinton (N.Y.) and Murray (Wash.) say they will stall the nomination after an unsuccessful briefing with the FDA acting commissioner over the agency's handling of Barr's Plan B emergency contraceptive OTC switch application.

You may also be interested in...

FDA's Plan B OTC Switch Decision Deadline Is Sept. 1, HHS' Leavitt Says

Sens. Clinton and Murray lift their hold on FDA Acting Commissioner Crawford's nomination after a letter from HHS secretary says FDA action on Barr's Rx-to-OTC switch application is imminent.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts